Expression of E-cadherin in drug resistant human breast cancer cells and their sensitivity to lymphokine-activated lymphocytes action
Aim: To analyze the correlation between the elevated sensitivity of drug resistant breast cancer cells to the action of lymphokine-activated lymphocytes (LAK) and expression of E-cadherin and other marker proteins by cancer cells and lymphocytes. Methods: Breast tumor explants were cultured with aut...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2009 |
| Main Authors: | Berezhnaya, N.M., Belova, O.B., Vinnichuk, Yu.D., Tarutinov, V.I. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2009
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/138143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Expression of E-cadherin in drug resistant human breast cancer cells and their sensitivity to lymphokine-activated lymphocytes action / N.M. Berezhnaya, O.B. Belova, Yu.D. Vinnichuk, V.I. Tarutinov // Experimental Oncology. — 2009. — Т. 31, № 4. — С. 242-245. — Бібліогр.: 28 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Antitumor action of lymphokin-activated сеlls of patients with soft tissue sarcomas and melanomas in dependence on expression of MHC classes I and II antigenes
by: Berezhnaya, N.M., et al.
Published: (2006)
by: Berezhnaya, N.M., et al.
Published: (2006)
Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
by: Bereznaya, N.M., et al.
Published: (2008)
by: Bereznaya, N.M., et al.
Published: (2008)
Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
by: I. V. Chorna, et al.
Published: (2014)
by: I. V. Chorna, et al.
Published: (2014)
Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
by: Chorna, I.V., et al.
Published: (2014)
by: Chorna, I.V., et al.
Published: (2014)
The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and В16 melanoma resistant to doxorubicin
by: Berezhnaya, N.M., et al.
Published: (2008)
by: Berezhnaya, N.M., et al.
Published: (2008)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors
by: Shcherbina, V., et al.
Published: (2023)
by: Shcherbina, V., et al.
Published: (2023)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
The clinical significance of soluble E-cadherin in nonsmall cell lung cancer
by: Charalabopoulos, K., et al.
Published: (2006)
by: Charalabopoulos, K., et al.
Published: (2006)
Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
by: Chekhun, V.F., et al.
Published: (2009)
by: Chekhun, V.F., et al.
Published: (2009)
Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
by: V. F. Chekhun, et al.
Published: (2016)
by: V. F. Chekhun, et al.
Published: (2016)
E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies
by: Mitselou, A., et al.
Published: (2007)
by: Mitselou, A., et al.
Published: (2007)
Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)
by: Yu. Lukianova, et al.
Published: (2015)
Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer
by: Lurchenko, N.P., et al.
Published: (2014)
by: Lurchenko, N.P., et al.
Published: (2014)
Disturbances in lipid second messengers generation by stimulated blood lymphocytes in breast cancer
by: Lazyan, M.P., et al.
Published: (2011)
by: Lazyan, M.P., et al.
Published: (2011)
Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer
by: Yu, Z., et al.
Published: (2007)
by: Yu, Z., et al.
Published: (2007)
The activity of adenosine monophosphate-activated protein kinase in lymphocytes under the action of hypoglycemic drugs
by: L. K. Sokolova, et al.
Published: (2017)
by: L. K. Sokolova, et al.
Published: (2017)
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)
by: Lukianova, N.Yu., et al.
Published: (2016)
Different morphological structures of breast tumors demonstrate individual drug resistance gene expression profiles
by: Gerashchenko, T.S., et al.
Published: (2018)
by: Gerashchenko, T.S., et al.
Published: (2018)
Different morphological structures of breast tumors demonstrate individual drug resistance gene expression profiles
by: Gerashchenko, T.S., et al.
Published: (2018)
by: Gerashchenko, T.S., et al.
Published: (2018)
Fractal dimension of the breast cancer cells resistant and sensitive to doxorubicin activity
by: Medviediev, O., et al.
Published: (2016)
by: Medviediev, O., et al.
Published: (2016)
Heterogeneity of premetastatic niches gene expression in breast cancer cells
by: L. A. Tashireva, et al.
Published: (2015)
by: L. A. Tashireva, et al.
Published: (2015)
Heterogeneity of premetastatic niches gene expression in breast cancer cells
by: Tashireva, L.A., et al.
Published: (2015)
by: Tashireva, L.A., et al.
Published: (2015)
The role of cadherin/catenin complex in malignant melanoma
by: Bonitsis, N., et al.
Published: (2006)
by: Bonitsis, N., et al.
Published: (2006)
Sensitivity to 4-hydroxyestradiol and dna repair efficiency in peripheral blood lymphocytes of endometrial cancer patients
by: Buchynska, L.G., et al.
Published: (2018)
by: Buchynska, L.G., et al.
Published: (2018)
Lymphocyte count in peripheral blood is a sensitive tool in pretreatment assessment of patients with urological cancer
by: Yakovlev, P., et al.
Published: (2018)
by: Yakovlev, P., et al.
Published: (2018)
Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer
by: N. P. Iurchenko, et al.
Published: (2014)
by: N. P. Iurchenko, et al.
Published: (2014)
Visualization of iron nanoparticles accumulation and distribution features in sensitive and resistant to antitumor drugs human breast cancer cells after different time intervals of cultivation with liposomal ferromagnetic
by: L. A. Nalieskina, et al.
Published: (2011)
by: L. A. Nalieskina, et al.
Published: (2011)
Sensitivity of human lymphocytes to genotoxic effect of N-methyl-N-nitrosourea: possible relation to gynecological cancers
by: Tronov, V.A., et al.
Published: (2006)
by: Tronov, V.A., et al.
Published: (2006)
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Tumor infiltrating lymphocytes and their impact on the effectiveness of the preoperative chemotherapy in various molecular subtypes of locally advanced breast cancer
by: N. O. Verovkina, et al.
Published: (2017)
by: N. O. Verovkina, et al.
Published: (2017)
Efficacy of different immunotherapy approaches toward treatment of doxorubicin-resistant and doxorubicinsensitive transplantable rhabdomyosarcoma
by: Belova, O.B., et al.
Published: (2007)
by: Belova, O.B., et al.
Published: (2007)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: S. V. Chekhun, et al.
Published: (2014)
by: S. V. Chekhun, et al.
Published: (2014)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: O. V. Shepil, et al.
Published: (2014)
by: O. V. Shepil, et al.
Published: (2014)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)
by: Chekhun, S.V., et al.
Published: (2014)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014)
by: Shepil, O.V., et al.
Published: (2014)
Expression of ITSN2 and TKS5 in different subtypes of breast cancer tumors
by: Kropyvko, S.V., et al.
Published: (2019)
by: Kropyvko, S.V., et al.
Published: (2019)
Hormonal-sensitive breast cancer: molecular-biological and clinical aspects of preoperative antitumor hormone therapy
by: O. V. Ponomareva
Published: (2018)
by: O. V. Ponomareva
Published: (2018)
Comparative study of dye-loaded liposome accumulation in sensitive and resistant human breast cancer cells
by: Yefimova, S.L., et al.
Published: (2012)
by: Yefimova, S.L., et al.
Published: (2012)
Epigenetics in breast cancer
by: C. Atalay
Published: (2013)
by: C. Atalay
Published: (2013)
Similar Items
-
Antitumor action of lymphokin-activated сеlls of patients with soft tissue sarcomas and melanomas in dependence on expression of MHC classes I and II antigenes
by: Berezhnaya, N.M., et al.
Published: (2006) -
Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
by: Bereznaya, N.M., et al.
Published: (2008) -
Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
by: I. V. Chorna, et al.
Published: (2014) -
Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
by: Chorna, I.V., et al.
Published: (2014) -
The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and В16 melanoma resistant to doxorubicin
by: Berezhnaya, N.M., et al.
Published: (2008)